Pharma

sponsor
Become a Member Today!
Register
Email:


Password:

Remember me
Forgot your Password?
Invite Code?
Article ID

Most Viewed Abstracts



Your Article Summary

(Click the title below to leave the MDLinx Network and go to the Journal's Website)

As well as the reprimands and warnings from the European Commission's much anticipated report on its Big Pharma antitrust investigations on Wednesday was the announcement that the EC is launching a new investigation into Servier. The regulators are accusing the private-held French company of hindering the launch of generic versions of its heart disease drug, perindopril, saying they suspect that the company did deals with generic rivals Krka, Lupin, Matrix, Niche Generics Ltd and Teva to hold back cheaper versions.

Today in Popular Press...keeping you current

Two Delivery Systems Win Baldrige Award
HealthDataManagement, 12/18/09

A holiday message from AHA President and CEO Rich Umbdenstock
American Hospital Association News, 12/11/09

Nursing I.T. Award Deadline Dec. 2
HealthDataManagement, 12/10/09

Article Search

Keyword:

Search:

Published within

Sort By:
Date
Relevance


Sponsor

Send this Summary to a Colleague

Enter email address